Patent details
EP1361884 Title: SENSITIZATION OF CHEMOTHERAPEUTIC AGENT RESISTANT NEOPLASTIC CELLS WITH REOVIRUS
Basic Information
- Publication number:
- EP1361884
- PCT Application Number:
- PCT/CA/2002/000201
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP027011220
- PCT Publication Number:
- WO/2002/066040
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- SENSITIZATION OF CHEMOTHERAPEUTIC AGENT RESISTANT NEOPLASTIC CELLS WITH REOVIRUS
- French Title of Invention:
- SENSIBILISATION DES CELLULES NEOPLASIQUES RESISTANT AUX AGENTS CHIMIOTHERAPEUTIQUES AVEC UN REOVIRUS
- German Title of Invention:
- SENSIBILISIERUNG VON FÜR CHEMOTHERAPEUTISCHE MITTEL RESISTENTEN NEOPLASTISCHEN ZELLEN DURCH REOVIREN
- SPC Number:
Dates
- Filing date:
- 19/02/2002
- Grant date:
- 20/07/2011
- EP Publication Date:
- 20/07/2011
- PCT Publication Date:
- 29/08/2002
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 19/11/2003
- EP B1 Publication Date:
- 20/07/2011
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 19/02/2012
- Expiration date:
- 19/02/2022
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 19/02/2002
- Name:
- Oncolytics Biotech Inc.
- Address:
- Suite 210 1167 Kensington Crescent N. W., Calgary, AB T2N 1X7, Canada (CA)
Inventor
1
- Name:
- THOMPSON Bradley, G.
- Address:
- Canada (CA)
2
- Name:
- COFFEY Matthew, C.
- Address:
- Canada (CA)
Priority
- Priority Number:
- 270363 P
- Priority Date:
- 20/02/2001
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 35/76;
| Filing date | Document type | Number of pages |
|---|